Detoxification Starts at the Membrane: The Science Behind a 30-Year Clinical Protocol
Long before “detox” became a wellness category, a different model of detoxification was taking shape in clinical practice. It began with Ed Kane’s own heavy-metal toxicity and the lipid science that followed, the foundation of the PK Protocol, and what BodyBio today frames as lipid replacement therapy, or cell membrane medicine.
The premise was simple: detoxification is a function of the cell membrane. The enzymes that biotransform toxins (cytochrome P450), the bile flow that carries them out, and the methylation that supports clearance all depend on intact phospholipid membranes. When membranes are depleted by environmental toxicants, oxidative stress, and nutrient deficiency, detoxification stalls, no matter the protocol layered on top.
In this live conversation, Dr. Kara Fitzgerald sits down with Pooja Mahtani, PharmD, MS, CNS, LDN, IFMCP and Jessica Berman, Co-Owner and Chief Brand Officer of BodyBio, to revisit the origins of the protocol, unpack the membrane hypothesis, and translate that science into a sequenced clinical framework: mineral repletion, phospholipid restoration, and targeted support: butyrate, TUDCA, and glutathione, to optimize clearance. It’s the same logic BodyBio has now formalized in its oral Cell Detox protocol.
You’ll leave able to:
- Explain why cell membrane integrity is a prerequisite for effective detoxification, and how environmental toxicants compromise it.
- Connect phospholipid depletion to reduced detoxification activity, impaired bile flow, and diminished toxin-clearance capacity.
- Review the clinical rationale behind phospholipid repletion for reducing toxic burden.
- Apply a sequenced protocol using minerals, phospholipids, butyrate, TUDCA, and glutathione.
Register to understand why the approach clinicians have trusted for three decades starts where detoxification happens… at the membrane.
Disclaimer: This event was for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider.
Dr. Pooja Mahtani, PharmD, MS, CNS, LDN, IFMCP
Dr. Pooja Mahtani, PharmD, MS, CNS, LDN, IFMCP, is the interim Director of Clinical & Scientific Affairs at BodyBio, where she leads clinical research initiatives and practitioner education focused on cellular health. With advanced training in pharmacy, nutrition, and functional medicine, she specializes in cell membrane health, phospholipid therapy, and evidence-based nutritional interventions. Pooja is passionate about translating complex science into practical clinical applications and educating healthcare practitioners on the foundations of cellular health.
Jessica Kane Berman, BodyBio Co-Owner & Chief Marketing Officer
Jessica Kane Berman is the Co-Owner and Chief Marketing Officer of BodyBio, where she leads strategic growth initiatives, marketing operations, and scientific outreach. Passionate about advancing evidence-based nutrition, Jessica champions BodyBio’s commitment to research, clinical education, and practitioner engagement. She works closely with leadership, research teams, and healthcare professionals to strengthen BodyBio’s position as a science-driven brand and bring innovative health solutions to clinicians and consumers alike.
